ورود
مقالات فارسیISIکنفرانسهاژورنالها

Long-term Disability and Poor Outcome Predictors of Guillain-Barre Syndrome in Children: A Systematic Review

محل انتشار: مجله پزشکی کودکان، دوره: 11، شماره: 1
سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 59

فایل این مقاله در 14 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:
https://civilica.com/doc/1837643

شناسه ملی سند علمی:

JR_JPRE-11-1_002

تاریخ نمایه سازی: 9 آذر 1402

چکیده مقاله:

Background: Guillain-Barre syndrome (GBS) is an immune-mediated polyneuropathy and a common cause of acute ascending weakness in children.  Objectives: This study aims to report long-term disability and poor outcome predictors of GBS in children. Medline (via Pubmed), Embase, Cochrane Library, Web of Science, and Scopus database was searched for relevant studies until April ۲۰۲۲, with a designated search strategy, using MeSH terms and free keywords. Methods: Studies evaluating functional outcomes of GBS in children with at least one year of follow-up were included. All studies achieved acceptable quality for inclusion. After selecting studies based on inclusion criteria, data were extracted based on a modified standardized Joanna Briggs Institute (JBI) data extraction tool, and the methodological quality of studies were reviewed using the Joanna Briggs Institute (JBI) critical appraisal tool. Results: Fourteen studies were included in this systematic review consisting of ۱۱۴۱ patients (۶۴۷ males, ۴۶۶ females, and ۲۸ unclassified). Follow-up duration varied from one year to ۱۱ years. The prevalence of the GBS subtype was as follows, acute inflammatory demyelinating polyneuropathies (AIDP) ۴۶.۶%, acute motor axonal neuropathy (AMAN) ۳۰.۲%, acute motor and sensory axonal neuropathy (AMSAN) ۶.۸% and Miller fisher ۶.۱%. The most commonly reported poor outcome after at least one year of follow-up was walking disabilities and gait disorders. Motor deficits and weakness, sensory complaints, including pain or paresthesia and fatigue were other prevalent residual symptoms. Axonal form of GBS was the most reported poor outcome predictor, followed by Hughes disability score >۳, a delay in independent walking, artificial ventilation, and rapid progression of symptoms. Conclusion: Despite the good prognosis of GBS in children, they could suffer long-term sequels, especially in walking abilities and gait. The axonal form is considered a crucial poor predictive factor.

کلیدواژه ها:

Children ، Difficulty walking ، Guillain-barre syndrome ، Prognosis

نویسندگان

Vahideh Toopchizadeh

Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Science, Tabriz, Iran.

Mohammad Barzegar

Pediatric Health Research Center, Tabriz University of Medical Science, Tabriz, Iran.

Negar Taleschian-Tabrizi

Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Science, Tabriz, Iran.

Fariba Pashazadeh

Evidence Based Medicine Research Center, Tabriz University of Medical Science, Tabriz, Iran.

Nasim Rashedi

Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Science, Tabriz, Iran.

Masood Chahvechi-Akbari

Department of Physical Medicine and Rehabilitation, Children’s Medical Center, Tehran University of Medical Science, Tehran, Iran.

Ozra Noori

Evidence Based Medicine Research Center, Tabriz University of Medical Science, Tabriz, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Willison HJ, Jacobs BC, van Doorn PA. Guillain-barre syndrome. The ...
  • Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré ...
  • McGrogan A, Madle GC, Seaman HE, De Vries CS. The ...
  • Dhadke SV, Dhadke VN, Bangar SS, Korade MB. Clinical profile ...
  • Korinthenberg R, Mönting JS. Natural history and treatment effects in ...
  • Rantala H, Uhari M, Niemelä M. Occurrence, clinical manifestations, and ...
  • Asahina M, Kuwabara S, Suzuki A, Hattori T. Autonomic function ...
  • Pithadia AB, Kakadia N. Guillain-Barré syndrome (GBS). Pharmacological reports. ۲۰۱۰;۶۲(۲):۲۲۰-۳۲ ...
  • Zhang G, Li Q, Zhang R, Wei X, Wang J, ...
  • Tian J, Liu X, Zhang K, Cao C, Li T, ...
  • Yuki N, Hartung H-P. Guillain–barré syndrome. New England Journal of ...
  • Rozé B, Najioullah F, Fergé J-L, Dorléans F, Apetse K, ...
  • Eslamian F, Taleschian-Tabrizi N, Izadseresht B, Shakouri SK, Gholian S, ...
  • Darweesh SK, Polinder S, Mulder MJ, Baena CP, van Leeuwen ...
  • Vajsar J, Fehlings D, Stephens D. Long-term outcome in children ...
  • Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, ...
  • Institute JB. Joanna Briggs Institute reviewers’ manual: ۲۰۱۵ edition/supplement. Adelaide: ...
  • Munn Z, Moola S, Lisy K, Riitano D. The Systematic ...
  • Institute TJB. Ciritical Appraisal Tools [cited ۲۰۲۰ ۲۰ March]. Available ...
  • Hughes RA, Cornblath DR. Guillain-barre syndrome. The Lancet. ۲۰۰۵;۳۶۶(۹۴۹۷):۱۶۵۳-۶۶ ...
  • Hiraga A, Mori M, Ogawara K, Hattori T, Kuwabara S. ...
  • Barzegar M, Toopchizadeh V, Maher MH, Sadeghi P, Jahanjoo F, ...
  • Chareyre J, Hully M, Simonnet H, Musset L, Barnerias C, ...
  • Akbayram S, Doğan M, Akgün C, Peker E, Sayιn R, ...
  • Varkal MA, Uzunhan TA, Aydınlı N, Ekici B, Çalışkan M, ...
  • Kalra V, Sankhyan N, Sharma S, Gulati S, Choudhry R, ...
  • Agarwal E, Bhagat A, Srivastava K, Thakore B, Jagtap S, ...
  • Chaweekulrat P, Sanmaneechai O. Prognostic model for time to achieve ...
  • Estrade S, Guiomard C, Fabry V, Baudou E, Cances C, ...
  • Incecik F, Hergüner MO, Altunbasak S. Guillain–Barré syndrome in children. ...
  • Karalok ZS, Taskin BD, Yanginlar ZB, Gurkas E, Guven A, ...
  • Konuşkan B, Okuyaz C, Taşdelen B, Kurul SH, Anlar B, ...
  • Lee JH, Sung IY, Rew IS. Clinical presentation and prognosis ...
  • Hughes R, Newsom-Davis J, Perkin G, Pierce J. Controlled trial ...
  • Roodbol J, de Wit MCY, Aarsen FK, Catsman‐Berrevoets CE, Jacobs ...
  • Hung P-L, Chang W-N, Huang L-T, Huang S-C, Chang Y-C, ...
  • Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF. Long-term outcome ...
  • Lawn ND, Wijdicks EF. Fatal Guillain-Barré syndrome. Neurology. ۱۹۹۹;۵۲(۳):۶۳۵- ...
  • Cole G, Matthew D. Prognosis in severe Guillain-Barré syndrome. Archives ...
  • Koul RL, Alfutaisi A. Prospective study of children with Guillain-Barre ...
  • Newswanger DL, Warren CR. Guillain-Barré syndrome. American family physician. ۲۰۰۴;۶۹(۱۰) ...
  • Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, ...
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting ...
    • نمایش کامل مراجع